EC Number |
Inhibitors |
Structure |
---|
3.4.21.105 | (3S,4S)-1-[(4-chlorophenyl)sulfonyl]-3-methyl-4-phenylazetidin-2-one |
- |
|
3.4.21.105 | (3S,4S)-3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one |
- |
|
3.4.21.105 | (3S,4S)-3-methyl-1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one |
- |
|
3.4.21.105 | 1,2-dihexanoyl-sn-glycero-3-phosphocholine |
1,2-dimyristoyl-sn-glycero-3-phosphocholine additionally added, paGlpG purified in detergent causes 37% reduction in activity |
|
3.4.21.105 | 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
paGlpG purified in detergent causes 5% reduction in activity |
|
3.4.21.105 | 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3,3,3-trifluoro-2-(trifluoromethyl)propan-1-one |
- |
|
3.4.21.105 | 1-(biphenyl-3-ylsulfonyl)-4-phenylazetidin-2-one |
- |
|
3.4.21.105 | 1-(biphenyl-4-ylsulfonyl)-4-phenylazetidin-2-one |
- |
|
3.4.21.105 | 1-myristoyl-sn-glycero-3-phosphocholine |
paGlpG purified in detergent causes 10% reduction in activity |
|
3.4.21.105 | 1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) |
paGlpG purified in detergent causes 20% reduction in activity |
|